GSK3B and non-small cell lung carcinoma: Astragaloside IV, an active ingredient in Astragalus membranaceus, inhibited non-small cell lung cancer development via inhibition of the Akt/GSK-3β/β-catenin signaling axis, resulting in the induction of apoptosis [63].